|
Model Number ONYXNG35022UX |
Device Problems
Device Dislodged or Dislocated (2923); Material Deformation (2976); Positioning Problem (3009)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 03/26/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
An attempt was made to use one onyx frontier coronary drug eluting stent (des) to treat a moderately tortuous, moderately calcified lesion with 90% stenosis located in the mid right coronary artery (rca).The lesion had in-stent restenosis (isr).The device was inspected with no issues.Negative prep was not performed.The lesion was pre-dilated.The device did pass through a previously deployed stent.Resistance was encountered when advancing the device.Excessive force was not used during delivery.It was reported that stent dislodgement occurred during removal following a failed delivery.It was stated that the stent was dislodged while attempting to pull it back after it would not cross the primary lesion. no issues were noted and while attempting to pull the stent back not a lot of tension or pull was noted.The stent became dislodged and went to the internal iliac artery.The vascular surgery and other interventional cardiologist (ic) operators were contacted, and it was decided to leave the stent.Two days later the patient needed the circumflex artery treated, therefore, a femoral approach was used, and the dislodged stent was snared from internal iliac artery. the patient is alive with no further injury.
|
|
Manufacturer Narrative
|
Product analysis: the stent was returned for evaluation.Only the dislodged stent returned.Deformation was evident on the returned stent.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|